Covered recipient · General Payments record
SHEELA VARDEY
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$2,463.95
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $894.85 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $563.35 | 18 |
| Novo Nordisk AS | $153.68 | 9 |
| DEXCOM, INC. | $48.72 | 2 |
| Mylan Specialty L.P. | $27.38 | 1 |
| Lilly USA, LLC | $24.71 | 1 |
| Janssen Pharmaceuticals, Inc | $22.63 | 1 |
| ALK-Abello, Inc | $20.64 | 1 |
| Acerta Pharma LLC | $20.20 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ALK-Abello, Inc | $20.64 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099896077 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.20 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104587430 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.54 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117995558 | CMS |
| Corium, LLC | $29.41 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100075845 | CMS |
| Corium, LLC | $29.65 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100075503 | CMS |
| Corium, LLC | $32.18 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100072765 | CMS |
| Corium, LLC | $32.78 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100072107 | CMS |
| Corium, LLC | $33.69 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100071353 | CMS |
| Corium, LLC | $33.38 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100071597 | CMS |
| Corium, LLC | $34.39 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100205642 | CMS |
| Corium, LLC | $30.06 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100200967 | CMS |
| Corium, LLC | $34.40 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100205658 | CMS |
| Corium, LLC | $33.54 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100204842 | CMS |
| Corium, LLC | $7.81 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100150909 | CMS |
| Corium, LLC | $33.54 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100204854 | CMS |
| Corium, LLC | $34.47 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100205734 | CMS |
| Corium, LLC | $33.83 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100205176 | CMS |
| Corium, LLC | $30.60 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100201614 | CMS |
| Corium, LLC | $31.87 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100203082 | CMS |
| Corium, LLC | $34.90 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100218069 | CMS |
| Corium, LLC | $32.85 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100218143 | CMS |
| Dexcom, Inc. | $24.48 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153336083 | CMS |
| Dexcom, Inc. | $24.24 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153336085 | CMS |
| Janssen Pharmaceuticals, Inc | $22.63 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078142699 | CMS |
| Lilly USA, LLC | $24.71 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135375380 | CMS |
| Mylan Specialty L.P. | $27.38 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147285276 | CMS |
| Novo Nordisk Inc | $18.03 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097141875 | CMS |
| Novo Nordisk Inc | $17.97 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097230584 | CMS |
| Novo Nordisk Inc | $17.96 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097302709 | CMS |
| Novo Nordisk Inc | $17.96 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097166289 | CMS |
| Novo Nordisk Inc | $15.71 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096888448 | CMS |
| Novo Nordisk Inc | $19.63 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097479211 | CMS |
| Novo Nordisk Inc | $22.64 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096975581 | CMS |
| Novo Nordisk Inc | $2.75 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097250509 | CMS |
| Novo Nordisk Inc | $21.03 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097453912 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.